Acute myeloblastic leukemia following chemotherapy for mycosis fungoides
- 1 March 1982
- journal article
- research article
- Published by American Medical Association (AMA) in Archives of Dermatology
- Vol. 118 (3) , 179-182
- https://doi.org/10.1001/archderm.118.3.179
Abstract
The development of acute myeloblastic leukemia following therapy for malignant disorders is being recognized with increasing frequency. Acute myeloblastic leukemia (erythroleukemic variant) developed in a patient with mycosis fungoides following 3 yr of chemotherapy with a variety of antineoplastic drugs. The patient demonstrated a hypodiploid chromosomal abnormality with a missing C group chromosome.This publication has 7 references indexed in Scilit:
- Mycosis fungoides: Clinicopathologic relationships, survival, and therapy in 59 patients with observations on occupation as a new prognostic factorCancer, 1980
- Prospective Staging Evaluation of Patients with Cutaneous T-Cell LymphomasAnnals of Internal Medicine, 1980
- Acute leukemia and immunosupressive drug use: a review of patients undergoing immunosuppressive therapy for non-neoplastic diseasesArchives of internal medicine (1960), 1979
- Breast cancer and acute leukemia: Report of 24 cases and review of the literatureAmerican Journal of Hematology, 1978
- Acute Leukemia after Alkylating-Agent Therapy of Ovarian CancerNew England Journal of Medicine, 1977
- Topical chemotherapy and immunotherapy of mycosis fungoides: intermediate-term resultsArchives of Dermatology, 1977
- Mycosis fungoidesThe American Journal of Medicine, 1963